ArticleFrontiers in pharmacology2018

Commentary: Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy.

Javier Durán et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.